Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laurus Master Fund, Ltd. was a New York-based hedge fund managed by Laurus Capital Management, specializing in structured finance and Private Investment in Public Equity (PIPE) transactions. The fund was a significant financier for small-cap and micro-cap companies, with a heavy focus on the biotechnology, life sciences, and healthcare sectors during the early to mid-2000s. At its peak, the fund managed approximately $1.8 billion in assets and was known for providing capital to emerging companies through complex convertible debt instruments. However, following the 2008 financial crisis and significant redemption requests, the fund faced liquidity issues and entered official liquidation in the Cayman Islands in 2009.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laurus Master Fund.